The abstract is read at the publisher; the summary is JClub's.
Single-cell profiling of CD45+ immune cells in syngeneic orthotopic TNBC mouse models (4T1 and M6) shows early immune evasion across bone marrow, lymph nodes, lungs, and blood.
- Why it matters: Only a minority of patients respond to immune checkpoint blockade, and metastatic TNBC lacks biomarkers to guide stratification and combination therapy design.
- What they did: The study used scRNA-seq across five anatomical sites over four tumor stages, validated by flow cytometry, then tested combined anti-LAG-3 plus anti-PD-1 versus anti-PD-1 alone.
- The result: Tumors showed myeloid dominance and T-cell dysfunction, while lymph-node antitumor signals were inactivated in tumor and lung tissues; dual LAG-3/PD-1 targeting reduced tumor size and metastatic burden more than PD-1 alone.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.